ASND Ascendis Pharma ADRs

Ascendis Pharma A/S is a biotechnology company that applies its TransCon technology to develop a pipeline of prodrug therapies with profiles that address markets with unmet medical needs. This is an ADR of a company that does not have its stock publicly traded anywhere else in the world.

$115.92  +3.01 (2.67%)
As of 07/28/2021 15:59:25 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  ADRs
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  Denmark
Country of incorporation:  
IPO date:  01/28/2015
Outstanding shares:  53,829,379
Average volume:  168,511
Market cap:   $6,064,956,132
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
CUSIP:    04351P101
ISIN:        US04351P1012
Sedol:      BV9G6B8
Valuation   (See tab for details)
PE ratio:   -14.53
PB ratio:   7.57
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy